Filter
801
Text search:
rifampicin
Featured
111
241
Language
Document type
566
104
61
28
13
12
9
4
2
1
1
Countries / Regions
57
56
32
23
23
19
16
14
13
13
12
12
12
12
11
10
9
9
9
9
9
8
7
7
6
5
5
5
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
298
109
18
18
16
12
5
Toolboxes
352
75
39
27
26
15
10
5
5
4
4
3
3
2
1
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed TB resistant isoniazid (INH). Drug resistance must
...
Accessed: 19.10.2019
HIV & AIDS Treatment in Practice No.202
Accessed July 2014.
Leprosy will be eliminated when we detect all patients and cure them by using multidrug therapy (MDT).
Elimination means bringing the disease burden down to a very low level. This will lead to a reduction in the source of infection, so that leprosy is likely to disappear naturally as it already h
...
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
Tuberculosis profile Population 2018
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region was 52 500 cases
The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.
